LivaNova (LIVN) Current Deferred Tax Assets (2015)

LivaNova (LIVN) posted Current Deferred Tax Assets of $4.4 million for Q4 2015, down 39.14% sequentially from $7.2 million in Q2 2015.

LivaNova (LIVN) Current Deferred Tax Assets (2015) Analysis & Trends

LivaNova has reported Current Deferred Tax Assets for 1 years, with the latest figure at $4.4 million in Q4 2015.

Quarterly Current Deferred Tax Assets changed N/A year-over-year to $4.4 million in Q4 2015, while the trailing twelve-month figure through Oct 2015 was $4.4 million (changed N/A YoY) and the FY2015 annual result came in at $7.2 million, changed N/A from the prior year.
Current Deferred Tax Assets retreated to $4.4 million in Q4 2015 per LIVN's latest filing, from $7.2 million in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $7.2 million in Q2 2015 and troughed at $4.4 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.85 Bn	194.25 Bn	7.27 Bn
2	Stryker	129.75 Bn	126.28 Bn	4.50 Bn
3	Medtronic	119.86 Bn	110.64 Bn	6.41 Bn
4	Boston Scientific	74.04 Bn	73.50 Bn	3.85 Bn
5	Edwards Lifesciences	52.51 Bn	48.26 Bn	1.35 Bn
6	Dexcom	34.75 Bn	32.81 Bn	830.00 Mn
7	GE HealthCare Technologies	34.16 Bn	32.05 Bn	2.18 Bn
8	Koninklijke Philips	26.43 Bn	23.11 Bn	4.55 Bn
9	Steris	23.26 Bn	22.78 Bn	684.20 Mn
10	LivaNova	4.32 Bn	3.81 Bn	273.67 Mn

Download Data